| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |



*
Research Unit and Nephrology Service, Reina Sofia University Hospital,
Córdoba
Nephrology Service, Hospital Clinic, Barcelona
Department of Pathology, Veterinary Faculty, University of
Córdoba,
Córdoba
§
Nephrology Service, Carlos Haya Hospital, Malaga, Spain
||
Department of Medicine, West Los Angeles VA Medical Center and UCLA, Los
Angeles, California.
Correspondence to Dr. Mariano Rodriguez, Unidad de Investigación, Hospital Reina Sofia, Avda Menendez Pidal s/n, 14004 Cordoba, Spain. Phone: 34-957-217229; Fax: 34-957-202542; E-mail: mrodriguez{at}sofia.hrs.sas.cica.es
Abstract. Calcitriol treatment is used to reduce parathyroid hormone levels in azotemic patients with secondary hyperparathyroidism (HPT). Whether long-term calcitriol administration reduces parathyroid gland size in patients with severe secondary hyperparathyroidism is not clear. The aim of the study was to evaluate in vitro the effect of calcitriol on parathyroid cell proliferation and apoptosis in normal parathyroid glands and in adenomatous and hyperplastic human parathyroid glands. Freshly harvested parathyroid glands from normal dogs and hyperplastic and adenomatous glands from patients with secondary (2°) and primary (1°) HPT undergoing parathyroidectomy were studied. Flow cytometry was used to quantify the cell cycle and apoptosis of parathyroid cells. Apoptosis was also evaluated by DNA electrophoresis and light and electron microscopy. In normal dog parathyroid glands, culture with calcitriol (10-10 to 10-7 M) for 24 h produced a dose-dependent inhibitory effect on the progression of cells into the cell cycle and into apoptosis. When glands from patients with 2°HPT were cultured for 24 h, only high calcitriol concentrations (10-7 M) inhibited the progression through the cell cycle and the induction of apoptosis. In parathyroid adenomas (1°HPT), even a high concentration of calcitriol (10-7 M) had no significant effect on the cell cycle or apoptosis. The present study shows that in vitro, calcitriol inhibits in a dose-dependent manner in normal parathyroid glands both parathyroid cell proliferation and apoptosis. However, in secondary hyperplasia, only high concentrations of calcitriol inhibited cell proliferation and apoptosis. In 1°HPT, even high concentrations of calcitriol had no effect. Because calcitriol simultaneously inhibits both cell proliferation and apoptosis, a reduction in the parathyroid gland mass may not occur as a direct effect of calcitriol treatment.
This article has been cited by other articles:
![]() |
N. Carrillo-Lopez, D. Alvarez-Hernandez, I. Gonzalez-Suarez, P. Roman-Garcia, J. M. Valdivielso, J. L. Fernandez-Martin, and J. B. Cannata-Andia Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3479 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shiizaki, I. Hatamura, S. Negi, E. Nakazawa, R. Tozawa, S. Izawa, T. Akizawa, and E. Kusano Cellular changes following direct vitamin D injection into the uraemia-induced hyperplastic parathyroid gland NDT Plus, August 1, 2008; 1(suppl_3): iii42 - iii48. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shiizaki, I. Hatamura, S. Negi, T. Sakaguchi, F. Saji, I. Imazeki, E. Kusano, T. Shigematsu, and T. Akizawa Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1529 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Riccardi and D. Martin The Role of the Calcium-Sensing Receptor in the Pathophysiology of Secondary Hyperparathyroidism NDT Plus, January 1, 2008; 1(suppl_1): i7 - i11. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Drueke, D. Martin, and M. Rodriguez Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839. [Full Text] [PDF] |
||||
![]() |
B Moosgaard, P Vestergaard, L Heickendorff, F Melsen, P Christiansen, and L Mosekilde Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol., August 1, 2006; 155(2): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Olgaard and E. Lewin Can Hyperparathyroid Bone Disease Be Arrested or Reversed? Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 367 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shiizaki, S. Negi, I. Hatamura, T. Sakaguchi, F. Saji, K. Kunimoto, M. Mizobuchi, I. Imazeki, A. Ooshima, and T. Akizawa Biochemical and Cellular Effects of Direct Maxacalcitol Injection into Parathyroid Gland in Uremic Rats J. Am. Soc. Nephrol., January 1, 2005; 16(1): 97 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okuno, E. Ishimura, K. Kitatani, H. Chou, K. Nagasue, K. Maekawa, T. Izumotani, T. Yamakawa, Y. Imanishi, T. Shoji, et al. Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2613 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Silver, R. Kilav, and T. Naveh-Many Mechanisms of secondary hyperparathyroidism Am J Physiol Renal Physiol, September 1, 2002; 283(3): F367 - F376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jara, S. Gonzalez, A. J. Felsenfeld, C. Chacon, A. Valdivieso, R. Jalil, and B. Chuaqui Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats Nephrol. Dial. Transplant., March 1, 2001; 16(3): 506 - 512. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673